MYC and osteosarcoma: Moreover, to investigate whether EGR1 facilitated anticancer effect of Scutellarin on osteosarcoma cell through regulating LINC00857/miR‐150‐5p/c‐Myc axis, we first inhibited EGR1 in 143B cells with or without LINC00857 knockdown, and then, these cells were treated with or without 500 μM Scutellarin for 48 h.